Victor Manuel Blanco-Alvarez
Overview
Explore the profile of Victor Manuel Blanco-Alvarez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
93
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tomas-Sanchez C, Blanco-Alvarez V, Gonzalez-Barrios J, Martinez-Fong D, Soto-Rodriguez G, Brambila E, et al.
Heliyon
. 2024 May;
10(9):e30017.
PMID: 38707461
The transient hypoxic-ischemic attack, also known as a minor stroke, can result in long-term neurological issues such as memory loss, depression, and anxiety due to an increase in nitrosative stress....
2.
Morales-Martinez A, Martinez-Gomez P, Martinez-Fong D, Villegas-Rojas M, Perez-Severiano F, Del Toro-Colin M, et al.
Int J Mol Sci
. 2022 Oct;
23(19).
PMID: 36232716
The α-synucleinopathies constitute a subset of neurodegenerative disorders, of which Parkinson's disease (PD) is the most common worldwide, characterized by the accumulation of misfolded α-synuclein in the cytoplasm of neurons,...
3.
Relevance of biometals during neuronal differentiation and myelination: in vitro and in vivo studies
Chin-Chan M, Montes S, Blanco-Alvarez V, Aguirre-Alarcon H, Hernandez-Rodriguez I, Bautista E
Biometals
. 2022 Mar;
35(3):395-427.
PMID: 35279793
Biometals are essential during the development of the central nervous system (CNS) since they participate in the organization and regulation of multiple processes related with the proper organization and functioning...
4.
Delgado-Minjares K, Martinez-Fong D, Martinez-Davila I, Banuelos C, Gutierrez-Castillo M, Blanco-Alvarez V, et al.
Int J Mol Sci
. 2021 Nov;
22(21).
PMID: 34769132
Parkinson's disease (PD) is characterized by four pathognomonic hallmarks: (1) motor and non-motor deficits; (2) neuroinflammation and oxidative stress; (3) pathological aggregates of the α-synuclein (α-syn) protein; (4) neurodegeneration of...
5.
Pacheco-Herrero M, Soto-Rojas L, Harrington C, Flores-Martinez Y, Villegas-Rojas M, Leon-Aguilar A, et al.
Front Neurol
. 2021 Apr;
12:660087.
PMID: 33912129
The current pandemic caused by the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a public health emergency. To date, March 1, 2021, coronavirus disease 2019 (COVID-19) has...
6.
Soto-Rojas L, Martinez-Davila I, Luna-Herrera C, Gutierrez-Castillo M, Lopez-Salas F, Gatica-Garcia B, et al.
Acta Neuropathol Commun
. 2020 Apr;
8(1):56.
PMID: 32321590
The spreading and accumulation of α-synuclein and dopaminergic neurodegeneration, two hallmarks of Parkinson's disease (PD), have been faithfully reproduced in rodent brains by chronic, oral administration of β-sitosterol β-D-glucoside (BSSG)....
7.
Tomas-Sanchez C, Blanco-Alvarez V, Gonzalez-Barrios J, Martinez-Fong D, Garcia-Robles G, Soto-Rodriguez G, et al.
J Immunol Res
. 2016 Sep;
2016:4039837.
PMID: 27635404
Acute and subacute administration of zinc exert neuroprotective effects in hypoxia-ischemia animal models; yet the effect of chronic administration of zinc still remains unknown. We addressed this issue by injecting...
8.
Blanco-Alvarez V, Soto-Rodriguez G, Gonzalez-Barrios J, Martinez-Fong D, Brambila E, Torres-Soto M, et al.
Neural Plast
. 2015 Sep;
2015:375391.
PMID: 26355725
Prophylactic subacute administration of zinc decreases lipoperoxidation and cell death following a transient cerebral hypoxia-ischemia, thus suggesting neuroprotective and preconditioning effects. Chemokines and growth factors are also involved in the...
9.
Blanco-Alvarez V, Lopez-Moreno P, Soto-Rodriguez G, Martinez-Fong D, Rubio H, Gonzalez-Barrios J, et al.
Oxid Med Cell Longev
. 2013 Sep;
2013:240560.
PMID: 23997853
Zinc or L-NAME administration has been shown to be protector agents, decreasing oxidative stress and cell death. However, the treatment with zinc and L-NAME by intraperitoneal injection has not been...